Cell Reports Medicine is a premium open-access journal from Cell Press publishing cutting-edge research in translational and clinical biomedical sciences that inform and influence human health and medicine. The content published in Cell Reports Medicine reaches a broad range of scientists and clinicians ...
Plos Medicine还保持在10分左右,2020年也大概10分的样子。Plos的其他杂志已经降低到5分左右。因为Plos one和Scientific Report每年出刊超过1万篇,我们没有计算出影响因子,望有经验者提供指导,如果可以计算的话,我们会在后续文章中分享给大家。 EMBO杂志的分数大概9分多,几个杂志的分数基本稳定, EMBO Molecular Medicin...
*This discount is valid for all authors who wish to publish open access and submit their article by 31 December 2024 177 days Submission to acceptance 27 days Acceptance to publication Articles Review articleOpen access scTrends: A living review of commercial single-cell and spatial 'omic technolo...
14). We found that six genes (i.e., Meis1, Gata2, Jun, Fos, Mycn, and Dusp1), which had similar expression trends along the pseudotime, were common driver regulators in all the three directions of cell fate commitment (Fig. 6c, d and Supplementary Fig. 15). The expression levels ...
Trends Cancer 2, 286–294 (2016). Article PubMed PubMed Central Google Scholar Baumann, M. et al. Radiation oncology in the era of precision medicine. Nat. Rev. Cancer 16, 234–249 (2016). CAS PubMed Google Scholar Galluzzi, L., Yamazaki, T. & Kroemer, G. Linking cellular ...
medicine. Specific donor-derived cell-free DNA (dd-cfDNA) is successfully applied as a non-invasive biomarker for transplant rejection [2,13,14,15], where early detection of allograft rejection is key in preventing allograft loss. cfDNA has already made a huge impact on prenatal medicine, ...
Department of Genetic Medicine, Cornell Medical College, New York, NY 10065, USA 6 The Mary M. Wohlford Laboratory for Male Contraceptive Research, Center for Biomedical Research, Population Council, 1230 York Avenue, New York, NY 10065, USA * Authors to whom correspondence should be addressed....
Key drivers of the cell therapy market are increasing clinical studies pertaining to the development of cellular therapies, growing adoption of regenerative medicine, and introduction of novel platforms and technologies. Request a Free Sample Table of Contents Chapter 1. Cell Therapy Market: Methodology...
6.1.12 Editas Medicine Inc. 6.1.13 CRISPR Therapeutic *List Not Exhaustive 7. MARKET OPPORTUNITIES AND FUTURE TRENDS **Subject to Availability **Competitive Landscape Covers - Business Overview, Financials, Products, Strategies, and Recent Developments. ...
and increased attention to regulatory and ethical considerations. Major trends expected in the forecast period encompass the adoption of 3D cell culture models, the use of high-throughput screening, the expansion of personalized medicine, the application of CRISPR-Cas9 and genome editing, and the focu...